A+ | A | A- | Skip to main content |

800 years stamp

Sensex

Nifty

USDINR

GBPINR

EURINR

BSE
NSE

Monday, 25 May 2026 12:00 AM EOD	Asian-Paints2656.40	Hind-Unilever2197.45	ITC304.00	Trent4299.10	Larsen-and-Toubro4033.30	M-and-M3138.85	Reliance-Industries1366.85	Tata-Steel210.20	Titan-Company4157.35	SBI969.90	Bharat-Electron421.75	Kotak-Mah-Bank392.75	Infosys1168.65	Bajaj-Finance942.00	Sun-PharmaInds1841.30	HDFC-Bank786.85	TCS2307.75	ICICI-Bank1291.60	Power-Grid-Corpn295.25	Maruti-Suzuki13170.70	Axis-Bank1311.70	HCL-Technologies1166.55	NTPC390.05	Bharti-Airtel1875.05	Tech-Mahindra1434.85	Adani-Ports1802.95	UltraTech-Cem11722.85	Bajaj-Finserv1807.20	Interglobe-Aviat4499.25	Eternal247.75
15 mins delay SENSEX 76,488.96 [1,073.61]	17.45 0.66%	-4.55 -0.21%	2.25 0.75%	3.35 0.08%	106.45 2.71%	56.70 1.84%	12.25 0.90%	1.00 0.48%	76.40 1.87%	20.80 2.19%	5.20 1.25%	8.55 2.23%	-5.75 -0.49%	25.65 2.80%	-3.90 -0.21%	20.45 2.67%	-9.50 -0.41%	26.70 2.11%	0.90 0.31%	183.25 1.41%	26.45 2.06%	2.80 0.24%	1.60 0.41%	3.65 0.20%	13.05 0.92%	16.50 0.92%	147.95 1.28%	41.90 2.37%	60.55 1.36%	5.80 2.40%

Hot Pursuit

Scrips, which has significant changes during the market hours.

Poly Medicure ends lower after Q4 PAT slumps 29% YoY to Rs 65 cr

25-May-26 17:20Hrs IST

Profit before tax (PBT) increased 30.63% YoY to Rs 85.22 crore in Q4 FY26.

Operating EBITDA dropped 8% to Rs 112.1 crore in Q4 FY26 from Rs 121.9 crore posted in Q4 FY25. EBITDA margin contracted to 667 bps to 21% in Q4 FY26 as against 27.6% in Q4 FY25.

Revenue from infusion therapy segment rose 1.9% YoY to Rs 256.1 crore while revenue from renal segment climbed 21.3% YoY to Rs 56.2 crore and revenue from others segment stood at Rs 222.1 crore, up 55.2% YoY.

On full year basis, the company's consolidated net profit fell 4.85% to Rs 322.13 crore on 12.3% increase in revenue from operations to Rs 1,875.25 crore in FY26 over FY25.

Meanwhile, the company's board recommended a dividend of Rs 3.5 per equity shares of Rs 5 each for the financial year 2025-26.

Poly Medicure exports plastic medical disposables/surgical devices. It manufactures and supplies approximately 100 types of disposable medical devices in the product verticals of infusion therapy, anesthesia, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis and central venous access catheters.

Powered by Capital Market - Live News

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

"Contents which are exclusively for Non-Broking Products/Services, "Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."

A Muthoot M George Enterprise